Deutsche Bank reduces its objective on Hermès to 2450? EUR and on LVMH to 600? EUR, while remaining at the purchase. Trigano benefits from an increase marked at 180? EUR at Exane, who also initiated Zealand Pharma in outperformance. Legrand sees two lens increases, at Deutsche Bank and Morgan Stanley.
- Amrize: Goldman Sachs starts neutral follow -up with a price target of 57 USD.
- Anheuser-Busch inBev: Morgan Stanley maintains his recommendation to overcome with a price of courses noted from 69 to 72 EUR.
- ArcelorMittal: Morgan Stanley maintains its market weighting recommendation with a reduced price target of 30 to 29.40 EUR.
- Arkema: Goldman Sachs maintains its neutral recommendation with a price of courses noted from 63 to 69 EUR.
- Bastide Medical Comfort: Portzamparc maintains its strong purchase recommendation and raises the price of courses from 35 to 41 EUR.
- Richemont Financial Company: Telsey Advisory Group maintains its market performance recommendation with a reduced course from 180 to 170 CHF.
- Edenred: Jefferies remains to be preserved with a reduced course target of 29.30 to 29 EUR.
- H. Lundbeck: BNP Paribas Exane starts up neutral follow -up with a 38 DKK course target.
- Hermès International: Deutsche Bank maintains its purchase recommendation with a reduced price target from 2550 to 2450 EUR.
- Legrand: Deutsche Bank maintains its purchase recommendation with a price of courses noted from 115 to 123 EUR. Morgan Stanley maintains his recommendation to overcome and raises the target of courses from 115 to 118 EUR.
- LVMH: Goldman Sachs maintains its purchase recommendation with a reduced course target from 610 to 600 EUR.
- Novo Nordisk: Goldman Sachs maintains its purchase recommendation with a reduced course target from 775 to 745 DKK.
- Nestlé: Deutsche Bank maintains its recommendation to keep with a reduced course target from 84 to 82 CHF.
- OVH: TP ICAP Midcap maintains its sales recommendation with a price of courses noted from 6 to 7.40 EUR.
- Pandora: Abg Sundal Collar degrades its purchasing advice to be preserved with a reduced course target of 1200 DKK to 1150 DKK.
- Schneider Electric: Goldman Sachs maintains his purchasing recommendation with a course of courses noted from 237 to 249 EUR.
- SEB SA: Stifel maintains its purchase recommendation and reduces the price of courses from 128 to 122 EUR.
- Siemens Energy: JP Morgan maintains its neutral recommendation with a price of courses noted from 58 to 78 EUR.
- Swedish Orphan Biovitrum: BNP Paribas Exane starts the follow -up in underperformance with a price target of 275 SEK.
- Temenos Group: Barclays maintains its market weighting recommendation with a reduced price target from 67 to 65 CHF.
- Trigano: BNP Paribas Exane maintains its overperformance recommendation with a price of courses noted from 140 to 180 EUR.
- Worldline: Jefferies remains to be preserved with a reduced course target of 4.60 to 3.80 EUR.
- Zealand Pharma: BNP Paribas Exane starts monitoring in outperformance with a price of 905 DKK lessons.
